http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0689839-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb54e0dd9573d32316a490e981fe014f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D315-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 1995-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9716e88a1a4040eb554d6a0447a39e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ee5c2f670b887fba00eacb4d53b8f5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb29cc0a5ed121899b4c6f4c447ff78c
publicationDate 1996-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0689839-A3
titleOfInvention Use of adenosine triphosphatase inhibitors for the manufacture of a medicament for the treatment of beta-amyloid peptide-associated disorders
priorityDate 1994-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0639644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5011827-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129322482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID417436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128247683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129672457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129586364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128055817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129198628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128849549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129806218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129241406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128499815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129468261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127899424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127832535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129188473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81529

Total number of triples: 58.